surpass-cvot tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular Outcomes in Type 2 Diabetes Read now: The SURPASS-EARLY trial

They also show promise for the treatment of many inflammatory diseases including asthma and inflammatory bowel disorders like Crohns disease and ulcerative colitis Diagram showing food stimulating the release of GLP-1 into the intestine and its effects on the brain, stomach and pancreas Importance In 2023 GLP-1 based drugs was named breakthrough of the year by Science , a prestigious American journal

It often leads to sarcopenic obesity, where muscle is lost and fat accumulates, which can reduce function and potentially affect long-term outcomes

How fast does the Grim Reaper walk

A.HolderN

De Fano M, Baluganti S, Manco M , et al